Efficiency and validity of commonly used substance abuse screening instruments in public psychiatric patients

Journal of Addictive Diseases

Volumn 17, Issue 2, 1998, Pages 57-76

  Dyson, Vida ^a   Appleby, Lawrence ^a   Altman, Edward ^a   Doot, Martin ^b   Luchins, Daniel J ^c   Delehant, Michelle ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Lutheran General Hospital   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Private Practice Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; OBSERVER VARIATION; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; REPRODUCIBILITY; SCREENING; SUBSTANCE ABUSE;

ADULT; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; SUBSTANCE-RELATED DISORDERS;

EID: 0031981592     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v17n02_05     Document Type: Article

References (51)

1. Drake RE, Alterman AI, Rosenberg SR. Detection of substance use disorders in severely mentally ill patients. Comm Ment Health J. 1993;29:175–192.
2. Kofoed L. Assessment of comorbid psychiatric illness and substance disor-ders. In: Minkoff K, Drake RE, eds. Dual diagnosis of major mental illness and substance disorder (New Directions for Mental Health Services). San Francis-co:Jossey-Bass; 1991:43–55.
3. Minkoff K. An integrated treatment model for dual diagnosis of psychosis and addiction. Hosp Comm Psychiat. 1989;40:1031–1036.
4. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LI, Goodwin FK. Comorbidity of mental disorders with alcohol and drug abuse. JAMA. 1990;264:2511–2518.
5. Chen C, Balogh M, Bathija J, Howanitz E, Plutchik R, Conte HR. Substance abuse among psychiatric patients. Compr Psychiat. 1992;33:60–64.
6. Ananth J, Vandewater S, Kamal M, Gamal R, Miller M. Missed diagnosis of substance abuse in psychiatric patients. Hosp Comm Psychiat. 1989;40: 297–299.
7. Albanese MJ, Bartel RL, Bruno RF, Morganbesser MW, Schatzberg AF. Comparison of measures used to determine substance abuse in an inpatient psychiatric population. Am J Psychiat. 1994;151:1077–1078.
8. Atkinson RM. Importance of alcohol and drug abuse in psychiatric emer-gencies. Calif Med. 1973;118:1–4.
9. Barbee JG, Clark PD, Crapanzano MS, Heintz GC, Kehoe CE. Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J Nerv Ment Dis. 1989;177:400–407.
10. Drake RE, Wallach MA. Substance abuse among the chronic mentally ill. Hosp Comm Psychiat. 1989;40:1041–1045.
11. Lyons JS, McGovern MP. Use of mental health services by dually diagnosed patients. Hosp Comm Psychiat. 1989;40:1067–1069.
12. Appleby L, Luchins DJ, Dyson V. Effects of mandatory drug screen on substance use diagnoses in a mental health population. J Nerv Ment Dis. 1995;183:183–184.
13. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schiz Bull. 1990;16:57–67.
14. Barry KL, Fleming MF, Greenley J, Widlak P, Kropp S, MCKee D. Assess-ment of alcohol and other drug disorders in the seriously mentally ill. Schiz Bull. 1995;21:313–321.
15. Mueser KT, Yarnold PR, Levinson DF, Sing H, Bellack AS, Kee K, Morrison RL, Yadalam KG. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schiz Bull. 1990;16:31–56.
16. Hedlund JL, Viewig BW. The Michigan Alcohol Screening Test (MAST): a comprehensive review. J Operational Psychiat. 1984;15:55–65.
17. McHugo GJ, Paskus TS, Drake RE. Detection of alcoholism in schizophrenia using the MAST. Alc Clin Exp Res. 1993;17:187–191.
18. Ewing A. Detecting alcoholism: the CAGE questionnaire. JAMA. 1984; 252:1905–1907.
19. Maisto SA, Connors GJ, Allen JP. Contrasting self-report screens for alcohol problems: a review. Alc Clin Exp Res. 1995;19:1510–1516.
20. Allen JP, Litten RZ. Psychometric and laboratory measures to assist in the treatment of alcoholism. Clin Psychol Rev. 1993;13:223–239.
21. Magruder-Habib K, Stevens HA, Alling WE. Relative performance of the MAST, VAST and CAGE versus DSM-III-R criteria for alcohol dependence. J Clin Epidemiol. 1993;4:435–441.
22. Baldessarini RJ, Finklestein S, Arana GW. The predictive power of diagnostic tests and the effect of prevalence of illness. Arch Gen Psychiatry. 1983; 40:569–573.
23. Sackett DL. A primer on the precision and accuracy of the clinical ex-amination. JAMA. 1992;267:2638–2644.
24. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983; 148:839–843.
25. Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL. Performance of screening and diagnostic tests: application of receiver operating characteristic analysis. Arch Gen Psychiatry. 1987;44:550–555.
26. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine 2nd ed. Boston: Little Brown & Co; 1991.
27. Ross HE, Gavin DR, Skinner HA. Diagnostic validity of the MAST and the Alcohol Dependence Scale in the assessment of DSM-III alcohol disorders. J Studies Alc. 1990;51:506–513.
28. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. Br J Addict. 1989;84:301–307.
29. Brown RL. Identification and office management of alcohol and drug dis-orders. In: Fleming MF, Barry KL eds. Addictive disorders. St. Louis:Mosby Year Book; 1992:25–43.
30. Selzer ML, Vinokur A, VanRoojen L. A self-administered short Michigan Alcohol Screening Test. J Studies Alc. 1975;9:27–38.
31. Skinner HA. The Drug Abuse Screening Test. Addict Behav. 1982;7:363–371.
32. McClellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diag-nostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26–33.
33. McGovern MP, Morrison DH. The Chemical Use, Abuse, and Dependence Scale (CUAD): rationale, reliability and validity. J Subst Abuse Treat. 1992; 9:27–38.
34. Mayfield D, McCleod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening questionnaire. Am J Psychiat. 1974;131:1121–1123.
35. Bush B, Shaw S, Cleary P, Delbanco TL, Aronson MD. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987; 82:231–235.
36. Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wisconsin Med J. 1995;94:135–140.
37. Selzer ML. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiat. 1971;127:89–94.
38. Zung BJ. Reliability and validity of the short MAST among psychiatric in-patients. J Clin Psychol. 1984;40:347–350.
39. Staley D, El-Guebaly N. Psychometric properties of the Drug Abuse Screening Test in a psychiatric patient population. Addict Behav. 1990;15:257–264.
40. Appleby L, Dyson V, Altman E, McGovern M, Luchins DJ. Applicability of the Chemical Use, Abuse, and Dependence Scale (CUAD) for screening substance-related disorders in severely mentally ill patients. Psych Services. 1996;47:647–649.
41. Hodgins DC, El-Guebaly N. More data on the Addiction Severity Index: reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis. 1992;180:197–201.
42. Lehman AF, Myers CP, Thompson JW, Corty E. Implications of mental and substance use disorders: a comparison of ‘’single” and ‘’dual” diagnosis patients. J Nerv Ment Dis. 1993;181:365–370.
43. Appleby L, Dyson V, Altman E, Luchins DJ. Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental health population. J Nerv Ment Dis. 1997;185:159–165.
44. Leigh G, Skinner HA. Physiological assessment. In: Donovan DM, Marlatt GA, eds. Assessment of Addictive Behaviors. New York: Guilford Press, 1988; 112–136.
45. Spritzer RL, Williams JBW, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID): history, rationale and description. Arch Gen Psychiatry. 1992;49:624–629.
46. Bartko JJ, Carpenter WT. On the methods and theory of reliability. J Nerv Ment Dis. 1976;163:307–317.
47. Carmines EG, Zeller RA. Reliability and validity assessment. Sage University Paper Series on Quantitative Applications in the Social Sciences (#17) Beverly Hills: Sage Publications; 1979.
48. Kitchens JM. Does this patient have an alcohol problem? JAMA. 1994;272:1762–1787.
49. Barry KA, Fleming MF. The Alcohol Use Disorders Identification Test (AUDIT) and the SMAST-13: Predictive validity in a rural primary care sample. Alcohol. 1993;28:33–42.
50. Fleming MF, Barry KL. The effectiveness of alcoholism screening in an ambulatory care setting. J Studies Alc. 1991; 52:33–36.
51. Appleby L, Dyson V, Luchins DJ, Cohen LS. The impact of substance use screening on a public psychiatric inpatient population. Psych Services. 1997; 48:1311–1316.